<qa>  What is the name of the clinical laboratory improvement act?- Patients must have a documented germline neurofibromatosis 1 NF1 mutation in a Clinical Laboratory Improvement Act CLIA certified laboratory or a diagnosis of NF1 based on clinical National Institutes of Health NIH consensus criteria; in addition to substantial cutaneous neurofibroma burden, at least one of the criteria below have to be present: 